This fall, the startup company Tivorsan Pharmaceuticals licensed rights from Brown to the key protein, biglycan, hoping to bring the potential therapy through clinical trials.
Just a week ago, my own efforts tobring about a more just and fair representation in the cabinet was met with teargas and gross violations of our fundamental rights of assembly and expression.